NEW YORK, Oct. 26, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Lexington Realty Trust (:LXP), Proteostasis Therapeutics, Inc. (PTI, Financial), PDC Energy, Inc. (PDCE, Financial), Twenty-First Century Fox, Inc. (FOXA, Financial), Square, Inc. (:SQ), and Sabra Healthcare REIT, Inc. (SBRA, Financial), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
LXP DOWNLOAD: http://MarketSourceResearch.com/register/?so=LXP
PTI DOWNLOAD: http://MarketSourceResearch.com/register/?so=PTI
PDCE DOWNLOAD: http://MarketSourceResearch.com/register/?so=PDCE
FOXA DOWNLOAD: http://MarketSourceResearch.com/register/?so=FOXA
SQ DOWNLOAD: http://MarketSourceResearch.com/register/?so=SQ
SBRA DOWNLOAD: http://MarketSourceResearch.com/register/?so=SBRA
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Market Source Research, available for free download at the links above, examine Lexington Realty Trust (:LXP), Proteostasis Therapeutics, Inc. (PTI, Financial), PDC Energy, Inc. (PDCE, Financial), Twenty-First Century Fox, Inc. (FOXA, Financial), Square, Inc. (:SQ), and Sabra Healthcare REIT, Inc. (SBRA, Financial) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed October 24th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
LEXINGTON REALTY TRUST (LXP, Financial) REPORT OVERVIEW
Lexington Realty Trust's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Lexington Realty Trust reported revenue of $105.49MM vs $95.68MM (up 10.25%) and analysts estimated basic earnings per share -$0.01 vs $0.02. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Lexington Realty Trust reported revenue of $391.64MM vs $429.50MM (down 8.81%) and analysts estimated basic earnings per share $0.33 vs $0.38 (down 13.16%). Analysts expect earnings to be released on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.25. The estimated EPS forecast for the next fiscal year is $0.77 and is expected to report on February 26th, 2019.
To read the full Lexington Realty Trust (LXP, Financial) report, download it here: http://MarketSourceResearch.com/register/?so=LXP
-----------------------------------------
PROTEOSTASIS THERAPEUTICS, INC. (PTI, Financial) REPORT OVERVIEW
Proteostasis Therapeutics' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Proteostasis Therapeutics reported revenue of $0.84MM vs $1.15MM (down 26.50%) and analysts estimated basic earnings per share -$0.43 vs -$0.68. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Proteostasis Therapeutics reported revenue of $5.34MM vs $8.38MM (down 36.30%) and analysts estimated basic earnings per share -$2.34 vs -$2.06. Analysts expect earnings to be released on November 13th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was -$0.56. The estimated EPS forecast for the next fiscal year is -$2.09 and is expected to report on March 13th, 2019.
To read the full Proteostasis Therapeutics, Inc. (PTI, Financial) report, download it here: http://MarketSourceResearch.com/register/?so=PTI
-----------------------------------------
PDC ENERGY, INC. (PDCE, Financial) REPORT OVERVIEW
PDC Energy's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, PDC Energy reported revenue of $212.53MM vs $275.16MM (down 22.76%) and analysts estimated basic earnings per share -$2.43 vs $0.63. For the twelve months ended December 31st, 2017 vs December 31st, 2016, PDC Energy reported revenue of $921.62MM vs $382.92MM (up 140.68%) and analysts estimated basic earnings per share -$1.94 vs -$5.01. Analysts expect earnings to be released on November 5th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was $0.08. The estimated EPS forecast for the next fiscal year is $4.87 and is expected to report on February 25th, 2019.
To read the full PDC Energy, Inc. (PDCE, Financial) report, download it here: http://MarketSourceResearch.com/register/?so=PDCE
-----------------------------------------
TWENTY-FIRST CENTURY FOX, INC. (FOXA, Financial) REPORT OVERVIEW
Twenty-First Century Fox's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Twenty-First Century Fox reported revenue of $7,941.00MM vs $6,748.00MM (up 17.68%) and basic earnings per share $0.50 vs $0.26 (up 92.31%). For the twelve months ended June 30th, 2018 vs June 30th, 2017, Twenty-First Century Fox reported revenue of $30,400.00MM vs $28,500.00MM (up 6.67%) and analysts estimated basic earnings per share $2.41 vs $1.59 (up 51.57%). Analysts expect earnings to be released on November 14th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.49. The estimated EPS forecast for the next fiscal year is $2.32 and is expected to report on August 14th, 2019.
To read the full Twenty-First Century Fox, Inc. (FOXA, Financial) report, download it here: http://MarketSourceResearch.com/register/?so=FOXA
-----------------------------------------
SQUARE, INC. (SQ, Financial) REPORT OVERVIEW
Square's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Square reported revenue of $814.94MM vs $551.51MM (up 47.77%) and analysts estimated basic earnings per share -$0.01 vs -$0.04. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Square reported revenue of $2,214.25MM vs $1,708.72MM (up 29.59%) and analysts estimated basic earnings per share -$0.17 vs -$0.50. Analysts expect earnings to be released on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.02. The estimated EPS forecast for the next fiscal year is $0.19 and is expected to report on February 26th, 2019.
To read the full Square, Inc. (SQ, Financial) report, download it here: http://MarketSourceResearch.com/register/?so=SQ
-----------------------------------------
SABRA HEALTHCARE REIT, INC. (SBRA, Financial) REPORT OVERVIEW
Sabra Healthcare REIT's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Sabra Healthcare REIT reported revenue of $166.31MM vs $64.74MM (up 156.91%) and analysts estimated basic earnings per share $1.09 vs $0.27 (up 303.70%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Sabra Healthcare REIT reported revenue of $405.65MM vs $260.53MM (up 55.70%) and analysts estimated basic earnings per share $1.40 vs $0.92 (up 52.17%). Analysts expect earnings to be released on November 5th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.60. The estimated EPS forecast for the next fiscal year is $2.49 and is expected to report on February 20th, 2019.
To read the full Sabra Healthcare REIT, Inc. (SBRA, Financial) report, download it here: http://MarketSourceResearch.com/register/?so=SBRA
-----------------------------------------
ABOUT MARKET SOURCE RESEARCH
Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at [email protected].
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: [email protected]
© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
